Wales' chief medical officer steps down

Sir Dr Frank Atherton is to stand down after eight-and-a-half years as the Welsh Government’s chief medical officer.

© Welsh Government

© Welsh Government

Sir Frank has provided independent advice to the Welsh Government on all major issues affecting the health sector in Wales.

During his tenure in Wales, after a previous post in Canada, Sir Frank played a leading role in Wales' response to the Covid-19 pandemic and has supported the NHS through flu outbreaks and annual winter pressures.

He has also been responsible for the development of health and care research.

Sir Frank said: ‘It has been a privilege to act as CMO and a highlight of my professional career to have served the people of Wales during this incredibly challenging time.

‘I would like to thank all those other civil servants, who have worked tirelessly behind the scenes, who have assisted me for almost a decade in this role.'

In response, health secretary Jeremy Miles, said: ‘Sir Frank has provided invaluable advice and guidance, which I am hugely grateful for.

‘He played a leading role in our response to the pandemic, ensuring people throughout Wales received valuable information about the virus and about how to keep themselves and their loved ones safe. I wish him all the best for the future.'

Judith Paget, chief executive of NHS Wales, added: ‘Frank has shown how passionate he is about improving health outcomes for the Welsh population and has led the way on improving the quality of healthcare.

‘It has been a privilege to work with him and to have the benefit of his experience and commitment to new approaches.'

AI turning point: The long-sought shift from reactive sick care to preventative healthcare

AI turning point: The long-sought shift from reactive sick care to preventative healthcare

By Lee Peart 17 September 2025

Benedikt von Thüngen, founder and chief executive of Sanome, says AI-driven decision support could mark a turning point toward a healthier, more resilient NH...

Former UKHSA boss appointed biotech investment company director

By Lee Peart 17 September 2025

Professor Dame Jenny Harries has been appointed non-executive director at The Biotech Growth Trust.

AI

Closing the reporting gap

By Lee Peart 17 September 2025

Joshua Burkhow, chief evangelist at Alteryx, explains how AI and automation can prove the ROI of analytics in the NHS


Popular articles by Liz Wells